HK Stock MarketDetailed Quotes

CENTRAL NEW EGY (01735)

Watchlist
  • 8.730
  • -0.090-1.02%
Market Closed Apr 24 16:06 CST
36.88BMarket Cap1091.25P/E (TTM)

CENTRAL NEW EGY (01735) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
82.64%11.02B
59.92%4.05B
49.74%6.03B
52.52%2.53B
149.64%4.03B
193.55%1.66B
48.55%1.61B
80.43%565.51M
190.81%1.09B
289.98%313.42M
Operating income
82.64%11.02B
59.92%4.05B
49.74%6.03B
52.52%2.53B
149.64%4.03B
193.55%1.66B
48.55%1.61B
80.43%565.51M
190.81%1.09B
289.98%313.42M
Cost of sales
-83.03%-10.81B
-59.22%-3.96B
-53.14%-5.9B
-56.18%-2.49B
-143.63%-3.86B
-188.83%-1.59B
-52.98%-1.58B
-86.05%-551.7M
-180.88%-1.03B
-269.23%-296.53M
Operating expenses
-83.03%-10.81B
-59.22%-3.96B
-53.14%-5.9B
-56.18%-2.49B
-143.63%-3.86B
-188.83%-1.59B
-52.98%-1.58B
-86.05%-551.7M
-180.88%-1.03B
-269.23%-296.53M
Gross profit
64.75%210.49M
100.06%86.43M
-26.07%127.77M
-35.10%43.2M
455.70%172.81M
381.97%66.57M
-39.93%31.1M
-18.22%13.81M
890.55%51.77M
29,020.69%16.89M
Selling expenses
-0.53%-20.1M
-51.08%-11.02M
-111.60%-19.99M
---7.29M
-162.15%-9.45M
----
56.35%-3.6M
----
-114.08%-8.26M
----
Administrative expenses
4.80%-164.47M
-5.50%-85.71M
-113.40%-172.76M
-127.05%-81.24M
3.10%-80.96M
-54.32%-35.78M
-76.91%-83.54M
32.95%-23.19M
-30.00%-47.22M
-96.35%-34.58M
Profit from asset sales
----
----
----
----
--1.64M
----
----
----
----
----
Revaluation surplus
----
----
-293.71%-10.04M
----
170.95%5.19M
----
-116.15%-7.31M
----
26.75%45.25M
----
-Changes in the fair value of investment property
----
----
-293.71%-10.04M
----
170.95%5.19M
----
-116.15%-7.31M
----
26.75%45.25M
----
Special items of operating profit
-32.76%122.85M
-36.53%91.66M
871.23%182.7M
1,938.59%144.41M
-50.32%18.81M
-62.12%7.08M
-8.56%37.87M
704.95%18.7M
1,191.33%41.41M
-0.77%2.32M
Operating profit
38.18%148.78M
-17.88%81.37M
-0.35%107.67M
161.62%99.09M
523.86%108.04M
306.12%37.88M
-130.73%-25.49M
160.69%9.33M
1,998.46%82.95M
-56.22%-15.37M
Financing cost
-29.54%-66.56M
-26.05%-30.2M
-103.99%-51.39M
-199.33%-23.96M
-356.34%-25.19M
-154.37%-8.01M
-61.73%-5.52M
-1,497.46%-3.15M
-4,390.79%-3.41M
-1,690.91%-197K
Share of profits of associates
--80K
----
----
----
----
----
----
----
----
----
Earning before tax
46.21%82.29M
-31.89%51.17M
-32.07%56.28M
151.52%75.13M
367.18%82.85M
383.41%29.87M
-138.99%-31.01M
139.70%6.18M
1,951.56%79.54M
-58.04%-15.56M
Tax
-886.64%-21.56M
92.52%-1.13M
81.11%-2.19M
-162.06%-15.07M
-1,795.60%-11.56M
-2,800.00%-5.75M
103.54%682K
113.40%213K
-325.10%-19.25M
24.11%-1.59M
After-tax profit from continuing operations
12.27%60.73M
-16.68%50.04M
-24.11%54.1M
149.00%60.06M
335.06%71.29M
277.33%24.12M
-150.31%-30.33M
137.26%6.39M
9,346.32%60.29M
-43.63%-17.15M
Earning after tax
12.27%60.73M
-16.68%50.04M
-24.11%54.1M
149.00%60.06M
335.06%71.29M
277.33%24.12M
-150.31%-30.33M
137.26%6.39M
9,346.32%60.29M
-43.63%-17.15M
Minority profit
150.66%26.49M
37.70%26.77M
-1,153.06%-52.3M
141.71%19.44M
299.84%4.97M
651.96%8.04M
-46.26%-2.49M
30.02%-1.46M
-1,851.55%-1.7M
---2.08M
Profit attributable to shareholders
-67.82%34.24M
-42.70%23.27M
60.42%106.39M
152.65%40.62M
338.20%66.32M
104.83%16.08M
-144.92%-27.84M
152.08%7.85M
8,375.70%61.99M
-26.20%-15.07M
Basic earnings per share
-67.86%0.0081
-42.71%0.0055
60.51%0.0252
152.63%0.0096
337.88%0.0157
-48.65%0.0038
-111.24%-0.0066
151.75%0.0074
8,485.71%0.0587
-26.55%-0.0143
Diluted earnings per share
-67.86%0.0081
-42.71%0.0055
60.51%0.0252
152.63%0.0096
337.88%0.0157
-48.65%0.0038
-111.24%-0.0066
151.75%0.0074
8,485.71%0.0587
-26.55%-0.0143
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 82.64%11.02B59.92%4.05B49.74%6.03B52.52%2.53B149.64%4.03B193.55%1.66B48.55%1.61B80.43%565.51M190.81%1.09B289.98%313.42M
Operating income 82.64%11.02B59.92%4.05B49.74%6.03B52.52%2.53B149.64%4.03B193.55%1.66B48.55%1.61B80.43%565.51M190.81%1.09B289.98%313.42M
Cost of sales -83.03%-10.81B-59.22%-3.96B-53.14%-5.9B-56.18%-2.49B-143.63%-3.86B-188.83%-1.59B-52.98%-1.58B-86.05%-551.7M-180.88%-1.03B-269.23%-296.53M
Operating expenses -83.03%-10.81B-59.22%-3.96B-53.14%-5.9B-56.18%-2.49B-143.63%-3.86B-188.83%-1.59B-52.98%-1.58B-86.05%-551.7M-180.88%-1.03B-269.23%-296.53M
Gross profit 64.75%210.49M100.06%86.43M-26.07%127.77M-35.10%43.2M455.70%172.81M381.97%66.57M-39.93%31.1M-18.22%13.81M890.55%51.77M29,020.69%16.89M
Selling expenses -0.53%-20.1M-51.08%-11.02M-111.60%-19.99M---7.29M-162.15%-9.45M----56.35%-3.6M-----114.08%-8.26M----
Administrative expenses 4.80%-164.47M-5.50%-85.71M-113.40%-172.76M-127.05%-81.24M3.10%-80.96M-54.32%-35.78M-76.91%-83.54M32.95%-23.19M-30.00%-47.22M-96.35%-34.58M
Profit from asset sales ------------------1.64M--------------------
Revaluation surplus ---------293.71%-10.04M----170.95%5.19M-----116.15%-7.31M----26.75%45.25M----
-Changes in the fair value of investment property ---------293.71%-10.04M----170.95%5.19M-----116.15%-7.31M----26.75%45.25M----
Special items of operating profit -32.76%122.85M-36.53%91.66M871.23%182.7M1,938.59%144.41M-50.32%18.81M-62.12%7.08M-8.56%37.87M704.95%18.7M1,191.33%41.41M-0.77%2.32M
Operating profit 38.18%148.78M-17.88%81.37M-0.35%107.67M161.62%99.09M523.86%108.04M306.12%37.88M-130.73%-25.49M160.69%9.33M1,998.46%82.95M-56.22%-15.37M
Financing cost -29.54%-66.56M-26.05%-30.2M-103.99%-51.39M-199.33%-23.96M-356.34%-25.19M-154.37%-8.01M-61.73%-5.52M-1,497.46%-3.15M-4,390.79%-3.41M-1,690.91%-197K
Share of profits of associates --80K------------------------------------
Earning before tax 46.21%82.29M-31.89%51.17M-32.07%56.28M151.52%75.13M367.18%82.85M383.41%29.87M-138.99%-31.01M139.70%6.18M1,951.56%79.54M-58.04%-15.56M
Tax -886.64%-21.56M92.52%-1.13M81.11%-2.19M-162.06%-15.07M-1,795.60%-11.56M-2,800.00%-5.75M103.54%682K113.40%213K-325.10%-19.25M24.11%-1.59M
After-tax profit from continuing operations 12.27%60.73M-16.68%50.04M-24.11%54.1M149.00%60.06M335.06%71.29M277.33%24.12M-150.31%-30.33M137.26%6.39M9,346.32%60.29M-43.63%-17.15M
Earning after tax 12.27%60.73M-16.68%50.04M-24.11%54.1M149.00%60.06M335.06%71.29M277.33%24.12M-150.31%-30.33M137.26%6.39M9,346.32%60.29M-43.63%-17.15M
Minority profit 150.66%26.49M37.70%26.77M-1,153.06%-52.3M141.71%19.44M299.84%4.97M651.96%8.04M-46.26%-2.49M30.02%-1.46M-1,851.55%-1.7M---2.08M
Profit attributable to shareholders -67.82%34.24M-42.70%23.27M60.42%106.39M152.65%40.62M338.20%66.32M104.83%16.08M-144.92%-27.84M152.08%7.85M8,375.70%61.99M-26.20%-15.07M
Basic earnings per share -67.86%0.0081-42.71%0.005560.51%0.0252152.63%0.0096337.88%0.0157-48.65%0.0038-111.24%-0.0066151.75%0.00748,485.71%0.0587-26.55%-0.0143
Diluted earnings per share -67.86%0.0081-42.71%0.005560.51%0.0252152.63%0.0096337.88%0.0157-48.65%0.0038-111.24%-0.0066151.75%0.00748,485.71%0.0587-26.55%-0.0143
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More